Appointments

Vistagen Appoints Angel S. Angelov as Chief Medical Officer to Advance Clinical Development Strategy

ATB Therapeutics Appoints Mark Throsby as CEO to Drive Clinical Development and Strategic Growth

OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer to Strengthen Financial and Capital Markets Strategy

TORL BioTherapeutics Appoints Dr. Aran Maree as Chief Executive Officer to Lead Next Stage of Clinical Growth

Adragos Pharma Appoints Kostas Rengis as Chief Executive Officer to Lead Next Phase of Global Growth

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer to Accelerate Growth Strategy

Halozyme Appoints Darren Snellgrove as Chief Financial Officer to Drive Strategic Financial Growth

Santhera Appoints Orlando Oliveira as Chief Executive Officer

ProBioGen Appoints Dr. Simon Johannes Bulling, PhD as Chief Operating Officer